Leukemia - Acute Myeloid - AML: Statistics

Approved by the Cancer.Net Editorial Board, 11/2014

ON THIS PAGE: You will find information about how many people are diagnosed with AML each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of the screen.

This year, an estimated 20,830 people of all ages (12,730 men and boys and 8,100 women and girls) in the United States will be diagnosed with AML. AML is the second most common type of leukemia diagnosed in both adults and children.

An estimated 10,460 deaths (6,110 men and boys and 4,350 women and girls) from AML will occur this year. The five-year survival rate is the percentage of people who survive at least five years after the cancer is found. The five-year survival rate of people with AML is approximately 25%. However, it is important to note that survival depends on several factors, including biologic features of the disease and, in particular, a patient’s age (see Subtypes for more information). Although AML is a serious disease, it is treatable and often curable with chemotherapy with or without a stem cell transplant (see the Treatment Options section).

Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States each year, so the actual risk for a particular individual may be different. It is not possible to tell a person how long he or she will live with AML. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.

Statistics adapted from the American Cancer Society's publication, Cancer Facts and Figures 2015.

The next section in this guide is Medical Illustrations and it offers drawings of body parts often affected by this disease. Or, use the menu on the left side of your screen to choose another section to continue reading this guide.